ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
스프라이셀 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보이며 2029년까지 연평균 4.6%의 성장률로 26억 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 전 세계 암 발병률 증가, 소아 적응증 승인, 암 치료제의 확대, 병용요법을 포함한 진행 중인 임상시험, 지속 가능한 의약품 제조에 대한 집중과 관련이 있습니다. 이 기간 동안 예상되는 주요 동향으로는 병용요법 접근법의 발전, 맞춤의료의 확대, 환자 친화적 제형 혁신, 치료 가이드라인의 업데이트, 표적 암 치료로의 지속적인 전환 등이 있습니다.
백혈병의 유병률 증가는 향후 몇 년 동안 스프라이셀 시장의 성장을 견인할 것으로 예측됩니다. 백혈병은 혈액과 골수를 침범하는 암으로 비정상적인 백혈구 과잉 생산이 특징입니다. 이 백혈병 환자 증가는 고령자가 이 질병에 걸리기 쉽고 진단 증가로 이어지기 때문에 고령화 인구와 큰 관련이 있습니다. 스프라이셀(다사티닙)은 필라델피아 염색체 양성 만성골수성백혈병(CML), 급성림프모구백혈병(ALL) 등 특정 유형의 백혈병에 효과적인 치료제입니다. 예를 들어, 미국 암 퇴치를 위한 비영리 단체인 미국암협회(ACS)는 2023년까지 약 5만 9,610명이 백혈병 진단을 받고 약 2만 3,940명이 사망할 것으로 예상하고 있습니다. 결과적으로 백혈병 발병률 증가가 스프라이셀 시장 성장에 기여하고 있습니다.
또한, 헬스케어 지출 증가도 스플릿셀 시장의 성장을 뒷받침할 것으로 예측됩니다. 헬스케어 지출은 특정 지역 내 또는 특정 기간 내에 헬스케어 서비스 및 제품에 할당되는 총 재정 자원을 의미합니다. 이 지출은 의료 기술의 발전으로 인해 증가하고 있으며, 고가의 진단 도구와 치료법을 채택하여 건강 결과를 개선하고 있습니다. 의료비 지출 증가는 의료 기관이 첨단 암 치료에 투자할 수 있게 함으로써 스프라이셀과 같은 혁신적인 암 치료제에 대한 폭넓은 접근을 촉진할 수 있습니다. 예를 들어, 2025년 4월 영국 통계청은 2023년부터 2024년까지 총 의료비 지출이 명목 기준으로 6.5% 증가하여 전년의 6.3% 증가보다 약간 높은 것으로 보고했습니다. 그 결과, 의료비 지출 증가가 스프라이셀 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 스프라이셀 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 스프라이셀 시장 : 성장률 분석
세계의 스프라이셀 시장 실적 : 규모와 성장, 2019-2024
세계의 스프라이셀 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 스프라이셀 전체 시장(TAM)
제6장 시장 세분화
세계의 스프라이셀 시장 : 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
만성 골수성 백혈병
급성 림프성 백혈병
세계의 스프라이셀 시장 : 제형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
경구 현탁액
세계의 스프라이셀 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진료소
소매 약국
온라인 약국
전문 약국
세계의 스프라이셀 시장 만성 골수성 백혈병 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
새롭게 진단된 만성기 CML
이마치니브 내성 또는 불내성 CML
가속기 CML
급성 전화기 CML
세계의 스프라이셀 시장 급성 림프성 백혈병 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
성인 필라델피아 염색체 양성(Ph+) ALL
소아 환자 필라델피아 염색체 양성(Ph+) ALL
재발성 또는 난치성 Ph+ALL
제7장 지역별/국가별 분석
세계의 스프라이셀 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 스프라이셀 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
스프라이셀 시장 : 경쟁 구도
스프라이셀 시장 : 기업 개요
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Otsuka Pharmaceutical Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Beacon Pharmaceuticals Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Panacea Biotec Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Apotex Corp. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Hubei Haosun Pharmaceutical Co. Ltd.
Dr. Reddy's Laboratories Ltd.
Lupin Limited
Zydus Lifesciences Limited
Biocon Limited
Zentiva k.s.
Alembic Pharmaceuticals Limited
Granules India Limited
Natco Pharma Limited
Shilpa Medicare Limited
Prasco Laboratories
Stason Pharmaceuticals Inc.
HRV Global Life Sciences Pvt. Ltd.
Sichuan Elixir Pharmaceutical Co. Ltd.
Gonane Pharma Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
스프라이셀 시장(2029년) : 새로운 기회를 제공하는 국가
스프라이셀 시장(2029년) : 새로운 기회를 제공하는 부문
스프라이셀 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Sprycel is a prescription drug mainly prescribed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by targeting specific proteins that drive the growth of cancer cells, helping to stop the unchecked multiplication of leukemia cells. This targeted therapy is especially beneficial for patients who do not respond to or cannot tolerate other treatment options.
The primary indications for Sprycel include chronic myeloid leukemia and acute lymphoblastic leukemia. CML is a slowly developing cancer of the blood and bone marrow, caused by a genetic alteration known as the Philadelphia chromosome. Sprycel is available in various dosage forms, including tablets and oral suspension, and is distributed through hospitals, clinics, retail and online pharmacies, as well as specialty pharmacies.
The sprycel market research report is one of a series of new reports from The Business Research Company that provides sprycel market statistics, including sprycel industry global market size, regional shares, competitors with a sprycel market share, detailed sprycel market segments, market trends and opportunities, and any further data you may need to thrive in the sprycel industry. This sprycel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sprycel market size has grown steadily in recent years. It will grow from $2.07 billion in 2024 to $2.17 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth observed during the historic period can be attributed to several factors, including a rise in the incidence of chronic myeloid leukemia, widespread use as a frontline treatment, advancements in diagnostic methods, expansion of the oncology drug pipeline, and the implementation of government reimbursement initiatives.
The sprycel market size is expected to see steady growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The projected growth in the forecast period can be linked to the rising global cancer burden, approvals for pediatric indications, expansion of oncology therapeutics, ongoing trials involving combination therapies, and a focus on sustainable pharmaceutical manufacturing. Key trends expected during this period include progress in combination treatment approaches, increased adoption of personalized medicine, innovation in patient-friendly drug formulations, updates in treatment guidelines, and a continued shift toward targeted cancer therapies.
The growing prevalence of leukemia is expected to drive the expansion of the Sprycel market in the coming years. Leukemia, a cancer affecting the blood and bone marrow, is marked by the excessive production of abnormal white blood cells. This increase in leukemia cases is largely linked to the aging population, as older individuals are more susceptible to the disease, leading to a rise in diagnoses. Sprycel (dasatinib) is an effective treatment for specific types of leukemia, including Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), as it inhibits the BCR-ABL protein responsible for cancer cell growth. For example, the American Cancer Society (ACS), a U.S.-based nonprofit organization focused on eliminating cancer, reported that approximately 59,610 individuals were diagnosed with leukemia in 2023, resulting in around 23,940 deaths. Consequently, the rising incidence of leukemia is contributing to the growth of the Sprycel market.
The increase in healthcare expenditure is also expected to support the growth of the Sprycel market. Healthcare expenditure refers to the total financial resources allocated to healthcare services and products within a specific region or over a certain period. This expenditure is rising due to technological advancements in medicine, which lead to the adoption of high-cost diagnostic tools and treatments that improve health outcomes. Increased spending on healthcare facilitates broader access to innovative cancer therapies such as Sprycel by enabling medical institutions to invest in advanced oncology treatments. For instance, in April 2025, the Office for National Statistics in the UK reported that total healthcare spending rose by 6.5% in nominal terms from 2023 to 2024, slightly exceeding the 6.3% growth recorded the previous year. As a result, higher healthcare expenditure is bolstering the Sprycel market's growth.
Key players in the Sprycel market are increasingly focusing on the development of generic versions of the drug to take advantage of the approaching expiration of exclusivity rights and meet the demand for more affordable cancer treatments. A generic version of Sprycel refers to dasatinib-based medications manufactured by other pharmaceutical companies after the original patent expires, offering equivalent therapeutic benefits at reduced costs. For instance, in September 2024, Apotex Corp., a Canadian pharmaceutical company, launched dasatinib tablets, a generic form of Sprycel used to treat certain types of leukemia. Dasatinib is a kinase inhibitor prescribed for adults and children aged one year and older with Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), particularly in patients who do not respond to or cannot tolerate previous treatments. The generic product adheres to stringent quality standards it is latex-free, sugar-free, dye-free, alcohol-free, and preservative-free and is available in bottles containing 30 or 60 tablets, depending on the dosage strength.
Major players in the sprycel market are Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co. Ltd., Beacon Pharmaceuticals Limited, Panacea Biotec Limited, Apotex Corp., Hubei Haosun Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Lifesciences Limited, Biocon Limited, Zentiva k.s., Alembic Pharmaceuticals Limited, Granules India Limited, Natco Pharma Limited, Shilpa Medicare Limited, Prasco Laboratories, Stason Pharmaceuticals Inc., HRV Global Life Sciences Pvt. Ltd., Sichuan Elixir Pharmaceutical Co. Ltd., Gonane Pharma Limited.
Asia-Pacific was the largest region in the sprycel market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in sprycel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sprycel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sprycel market consists of sales of products including film-coated tablets, powder for oral suspension, blister packaging, pediatric dosing packs, and flavoring agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sprycel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sprycel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sprycel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sprycel market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Indication: Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia
2) By Dosage Forms: Tablets; Oral Suspension
3) By Distribution Channel: Hospitals and Clinics; Retail Pharmacies; Online Pharmacies; Specialty Pharmacies
Subsegments:
1) By Chronic Myeloid Leukemia: Newly Diagnosed Chronic Phase CML; Imatinib-Resistant Or Intolerant CML; Accelerated Phase CML; Blast Phase CML
2) By Acute Lymphoblastic Leukemia: Philadelphia Chromosome-Positive (Ph+) ALL In Adults; Philadelphia Chromosome-Positive (Ph+) ALL In Pediatric Patients; Relapsed Or Refractory Ph+ ALL
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sprycel Market Characteristics
3. Sprycel Market Trends And Strategies
4. Sprycel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sprycel Growth Analysis And Strategic Analysis Framework
5.1. Global Sprycel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sprycel Market Growth Rate Analysis
5.4. Global Sprycel Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sprycel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sprycel Total Addressable Market (TAM)
6. Sprycel Market Segmentation
6.1. Global Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Myeloid Leukemia
Acute Lymphoblastic Leukemia
6.2. Global Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Oral Suspension
6.3. Global Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals and Clinics
Retail Pharmacies
Online Parmacies
Speciality Pharmacies
6.4. Global Sprycel Market, Sub-Segmentation Of Chronic Myeloid Leukemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Newly Diagnosed Chronic Phase CML
Imatinib-Resistant or Intolerant CML
Accelerated Phase CML
Blast Phase CML
6.5. Global Sprycel Market, Sub-Segmentation Of Acute Lymphoblastic Leukemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Philadelphia Chromosome-Positive (Ph+) ALL in Adults
Philadelphia Chromosome-Positive (Ph+) ALL in Pediatric Patients
Relapsed or Refractory Ph+ ALL
7. Sprycel Market Regional And Country Analysis
7.1. Global Sprycel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sprycel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sprycel Market
8.1. Asia-Pacific Sprycel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sprycel Market
9.1. China Sprycel Market Overview
9.2. China Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sprycel Market
10.1. India Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sprycel Market
11.1. Japan Sprycel Market Overview
11.2. Japan Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sprycel Market
12.1. Australia Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sprycel Market
13.1. Indonesia Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sprycel Market
14.1. South Korea Sprycel Market Overview
14.2. South Korea Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sprycel Market
15.1. Western Europe Sprycel Market Overview
15.2. Western Europe Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sprycel Market
16.1. UK Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sprycel Market
17.1. Germany Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sprycel Market
18.1. France Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sprycel Market
19.1. Italy Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sprycel Market
20.1. Spain Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sprycel Market
21.1. Eastern Europe Sprycel Market Overview
21.2. Eastern Europe Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sprycel Market
22.1. Russia Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sprycel Market
23.1. North America Sprycel Market Overview
23.2. North America Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sprycel Market
24.1. USA Sprycel Market Overview
24.2. USA Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sprycel Market
25.1. Canada Sprycel Market Overview
25.2. Canada Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sprycel Market
26.1. South America Sprycel Market Overview
26.2. South America Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sprycel Market
27.1. Brazil Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sprycel Market
28.1. Middle East Sprycel Market Overview
28.2. Middle East Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sprycel Market
29.1. Africa Sprycel Market Overview
29.2. Africa Sprycel Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Sprycel Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Sprycel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sprycel Market Competitive Landscape And Company Profiles
30.1. Sprycel Market Competitive Landscape
30.2. Sprycel Market Company Profiles
30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Beacon Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Panacea Biotec Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Apotex Corp. Overview, Products and Services, Strategy and Financial Analysis
31. Sprycel Market Other Major And Innovative Companies
31.1. Hubei Haosun Pharmaceutical Co. Ltd.
31.2. Dr. Reddy's Laboratories Ltd.
31.3. Lupin Limited
31.4. Zydus Lifesciences Limited
31.5. Biocon Limited
31.6. Zentiva k.s.
31.7. Alembic Pharmaceuticals Limited
31.8. Granules India Limited
31.9. Natco Pharma Limited
31.10. Shilpa Medicare Limited
31.11. Prasco Laboratories
31.12. Stason Pharmaceuticals Inc.
31.13. HRV Global Life Sciences Pvt. Ltd.
31.14. Sichuan Elixir Pharmaceutical Co. Ltd.
31.15. Gonane Pharma Limited
32. Global Sprycel Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sprycel Market
34. Recent Developments In The Sprycel Market
35. Sprycel Market High Potential Countries, Segments and Strategies
35.1 Sprycel Market In 2029 - Countries Offering Most New Opportunities
35.2 Sprycel Market In 2029 - Segments Offering Most New Opportunities
